IN VIVO CRO MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
In vivo CRO market involves contract research organizations (CROs) that help pharmaceutical and biotechnology companies in non-clinical or pre-clinical stages of drug development by outsourcing their research needs to these specialized firms. CROs conduct experiments and tests on live animals and help evaluate the efficacy, toxicity, and safety of new drug candidates. This reduces risks for drug developers and accelerates the drug approval process. Rising R&D expenditure on pharmaceuticals and medical innovations is a key driver for growth of the global in vivo CRO market. However, factors such as stringent animal welfare regulations and increasing demand for alternative testing methods pose challenges for the market.
Market Dynamics
The global in vivo CRO market is driven by rising pharmaceutical R&D expenditure, advancements in disease treatment, and growing need to reduce drug development timelines and costs. However, stringent regulations for animal testing and rising preference for alternative testing methods, such as organ-on-chip and in vitro testing, act as restraints for the market. Development of human-on-chip technology provides an opportunity for companies in this market to offer novel alternative testing solutions and align with industry shift toward non-animal methods. The COVID-19 outbreak highlighted the need for CROs to find treatments and help drug makers in pre-clinical research, thereby presenting lucrative prospects for players in this market.
Key Features of the Study:
Detailed Segmentation-
Table of Contents
*Browse 32 market data tables and 28 figures on "In Vivo CRO Market” - Global forecast to 2031
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
